Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration.
Adcock DM, Kressin DC, Marlar RA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of tube fill volume and citrate concentration (3.8% versus 3.2%) on PT and APTT in plasma from healthy volunteers and patients on anticoagulant therapy.
Summary of Findings
In plasma from healthy volunteers, PT was significantly increased by tube fill volumes of 70% or less in 3.8% citrate tubes and fill volumes of 50% or less in 3.2% citrate tubes. APTT was significantly increased in plasma from healthy volunteers by fill volumes of 80% or less in 3.8% citrate tubes and fill volumes of 60% or less in 3.2% citrate tubes. Clinically significant increases in PT in specimens from patients on oral anticoagulant therapy were seen with fill volumes of 80% or less in the 3.8% citrate tubes and with fill volumes of 70% or less in the 3.2% citrate tubes. Clinically significant increases in APTT were seen in specimens from patients on oral anticoagulant therapy with fill volumes of 70% or less in the 3.8% citrate tubes and 60% or less in the 3.2% citrate tubes.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
NormalNot specifiedPlatforms
MorphologyHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs NoneOral anticoagulant therapyBiospecimen Acquisition Anticoagulant CitrateMultiple concentrations evaluatedBiospecimen Aliquots and Components Aliquot size/volume 2.0 mL2.5 mL3.0 mL3.5 mL4.0 mL4.5 mL5.0 mLArbitrarily underfilled (<5.0 mL)